Czech National Bank lifted its holdings in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 6.2% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 548,475 shares of the company’s stock after buying an additional 32,108 shares during the period. Merck & Co., Inc. makes up about 0.5% of Czech National Bank’s holdings, making the stock its 27th largest holding. Czech National Bank’s holdings in Merck & Co., Inc. were worth $54,562,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. Darwin Wealth Management LLC bought a new position in Merck & Co., Inc. in the third quarter valued at approximately $32,000. AM Squared Ltd acquired a new stake in shares of Merck & Co., Inc. in the 3rd quarter valued at approximately $34,000. Safe Harbor Fiduciary LLC bought a new position in shares of Merck & Co., Inc. in the third quarter valued at $34,000. Peterson Financial Group Inc. acquired a new position in Merck & Co., Inc. during the third quarter worth $36,000. Finally, Itau Unibanco Holding S.A. bought a new stake in Merck & Co., Inc. during the second quarter worth $39,000. Institutional investors own 76.07% of the company’s stock.
Merck & Co., Inc. Stock Performance
NYSE MRK opened at $99.34 on Monday. Merck & Co., Inc. has a 12-month low of $94.48 and a 12-month high of $134.63. The firm has a 50-day moving average price of $100.18 and a two-hundred day moving average price of $110.57. The company has a market capitalization of $251.29 billion, a P/E ratio of 20.83, a P/E/G ratio of 1.47 and a beta of 0.39. The company has a quick ratio of 1.15, a current ratio of 1.36 and a debt-to-equity ratio of 0.79.
Merck & Co., Inc. Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, January 8th. Investors of record on Monday, December 16th were paid a $0.81 dividend. This represents a $3.24 dividend on an annualized basis and a yield of 3.26%. The ex-dividend date of this dividend was Monday, December 16th. This is an increase from Merck & Co., Inc.’s previous quarterly dividend of $0.77. Merck & Co., Inc.’s payout ratio is 67.92%.
Analyst Upgrades and Downgrades
A number of brokerages have recently commented on MRK. Cantor Fitzgerald reissued an “overweight” rating and issued a $155.00 price objective on shares of Merck & Co., Inc. in a research report on Thursday, October 3rd. Bank of America reiterated a “buy” rating and set a $121.00 price target on shares of Merck & Co., Inc. in a report on Tuesday, December 10th. Guggenheim dropped their price objective on Merck & Co., Inc. from $137.00 to $130.00 and set a “buy” rating on the stock in a research note on Wednesday, November 6th. Hsbc Global Res upgraded Merck & Co., Inc. from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, December 4th. Finally, Wolfe Research initiated coverage on Merck & Co., Inc. in a report on Friday, November 15th. They set a “peer perform” rating on the stock. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating, eight have issued a buy rating and four have given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $124.00.
Read Our Latest Stock Report on Merck & Co., Inc.
About Merck & Co., Inc.
Merck & Co, Inc is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.
Featured Stories
- Five stocks we like better than Merck & Co., Inc.
- How to Use the MarketBeat Dividend Calculator
- 3 Defensive Picks to Add Stability to Your Portfolio
- Compound Interest and Why It Matters When Investing
- AppLovin’s AI Potential: Can the Momentum Continue?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Global Macro Hedge Funds Dominated 2024: Strategies You Can Copy
Want to see what other hedge funds are holding MRK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck & Co., Inc. (NYSE:MRK – Free Report).
Receive News & Ratings for Merck & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.